Your session is about to expire
← Back to Search
Active Hand Orthosis
Hand Orthosis for Spinal Cord Injury
N/A
Recruiting
Led By Joel Stein, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Substantially reduced motor control and strength below the level of their SCI with regard to hand and finger function
Be older than 18 years old
Must not have
Fixed upper limb contractures that limit functional use of the hand and arm or ability to use the device
Severe spasticity (modified Ashworth >2) at elbow, wrist, or fingers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years at study completion
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing the MyHand-SCI device, which helps people with C6-C7 spinal cord injuries use their hands better. The device combines physical support and smart technology to improve hand movements.
Who is the study for?
This trial is for individuals with C6-C7 spinal cord injury who are at least 6 months post-injury and have significantly reduced hand and finger function. They must be able to consent to the study. People with open wounds, severe upper limb pain, intense spasticity, or fixed contractures that limit arm use cannot participate.
What is being tested?
The MyHand-SCI trial is testing a device designed to help people with specific spinal cord injuries regain hand functions. Participants will use the MyHand-SCI orthosis, which aims to improve their ability to perform daily tasks by enhancing motor control and strength in their hands.
What are the potential side effects?
Potential side effects may include discomfort from wearing the device, skin irritation where it contacts the body, muscle fatigue due to new movements or extended usage of the device, and possible exacerbation of existing spasticity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My hand and finger control is greatly reduced due to my spinal cord injury.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot use my hand or arm well because they are stiff and cannot move.
Select...
I have severe muscle stiffness in my arm or hand.
Select...
I have open wounds or my skin tears easily.
Select...
I have constant severe pain in my arm.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 years at study completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years at study completion
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
System Usability Scale
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: MyHand-SCI Device TestingExperimental Treatment1 Intervention
Subjects will attend 1-20 sessions (of approximately 90 mins) to trial a variety of the MyHand-SCI device controls and/or components. Participants will practice various grasp and release activities with the device
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Spinal Cord Injury (SCI) include physical therapy, occupational therapy, and assistive technologies like the MyHand-SCI device. Physical and occupational therapies aim to improve motor function and independence through targeted exercises and activities.
Assistive technologies, such as active hand orthoses, work by providing mechanical support and enhancing the user's ability to perform daily tasks. These treatments are crucial for SCI patients as they help restore some degree of function, improve quality of life, and promote greater independence.
Upper Extremity Assessment in Tetraplegia: The Importance of Differentiating Between Upper and Lower Motor Neuron Paralysis.
Upper Extremity Assessment in Tetraplegia: The Importance of Differentiating Between Upper and Lower Motor Neuron Paralysis.
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,498 Previous Clinical Trials
2,767,085 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,384 Previous Clinical Trials
652,648 Total Patients Enrolled
Joel Stein, MDPrincipal InvestigatorColumbia University
8 Previous Clinical Trials
280 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot use my hand or arm well because they are stiff and cannot move.My hand and finger control is greatly reduced due to my spinal cord injury.I have open wounds or my skin tears easily.I have constant severe pain in my arm.I have a spinal cord injury at C6-C7 and my arms don't work well, 6 months after the injury.I have severe muscle stiffness in my arm or hand.
Research Study Groups:
This trial has the following groups:- Group 1: MyHand-SCI Device Testing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Spinal Cord Injury Patient Testimony for trial: Trial Name: NCT05553457 — N/A